Articles By Eric Larson
-
Don't Just Transform Once. Transform Continuously.
1/21/2026
Rigid, one-time transformations can’t keep up with today’s disruptions. Continuous Transformation offers an iterative, agile approach that drives resilience and sustained progress.
-
The 5-Layer Fix For AI Failure In Pharmaceutical Manufacturing
1/21/2026
The promise of AI is colliding with the harsh reality of data chaos in pharma manufacturing. This article explores why most AI investments fail, and a 5-layer solution.
-
Why Use Total Organic Carbon Analysis For Cleaning Validation?
1/21/2026
Total organic carbon analysis is probably the most “fit for use” analytical method to validate cleaning processes, particularly within a science- and risk-based approach.
-
Reduce PFAS Risk With Screening And Testing
1/20/2026
With evolving global regulations and growing concerns about risk, understanding PFAS in your devices is critical. Eurofins offers advanced PFAS screening and testing solutions.
-
01.20.26 -- Digital Surgery 2026: Inside The Data-Driven Operating Room
1/20/2026
01/20/26 Med Device Online Newsletter
-
01.18.26 -- Unpacking The EU's Mutual Recognition Agreements
1/18/2026
01/18/26 Med Device Online Newsletter
-
The Guide To Balancing Citizen Development And Governance
1/16/2026
Discover how manufacturers can balance citizen development with governance, enabling frontline innovation while maintaining compliance, as well as success stories that show how to scale no-code solutions.
-
Digital Transformation In Life Sciences With Validation 4.0
1/16/2026
Pharma 4.0 demands a new approach to validation. Learn how risk-based strategies, integrated environments, and modern documentation accelerate digital transformation while ensuring compliance.
-
Accumold Makes Pharmapack Europe Debut To Support Next-Generation Drug Delivery And Pharma Packaging
1/15/2026
See how precision micro molding enables scalable, reliable drug delivery and pharmaceutical packaging designs as industry experts debut at Pharmapack Europe 2026 in Paris, January 21–22.
-
AbbVie To Buy Device Manufacturing Facility From West Pharmaceutical Services
1/14/2026
The acquisition of the Tempe, Arizona facility will expand U.S.-based drug delivery device capacity and support the company’s $10 billion manufacturing investment.